Hein P M, Schulz E
Institut für Rechtsmedizin, Universität Würzburg.
Blutalkohol. 1992 Jul;29(4):226-41.
The question of recognition and possibilities of proof regarding impairment by narcotics and drugs is gaining significance also in Germany. Therefore, it is necessary to deal more closely with the United States "Drug Evaluation and Classification Program" and consider its application in Germany as well. The American program is based on standardized education of drug recognition expert trainees and well-tested methods of examination. The results are convincing. The expert reports prepared by the examiners and the chemical-toxicological results correlate in 80 to 97% of the cases. As long as no definite findings regarding dose/concentration effect relationships exist, the classification of behavior, appearance and medical examination plays a significant role. To a great extent, the program makes allowance for the existing possibilities in Germany as well. The authors of this article would consider it to be wrong if, in Germany extensive, time-consuming field studies were undertaken to obtain further knowledge prior to introduction of such a program. On the other hand, despite the existing difficulties, it should be endeavored to find dose/concentration effects.
在德国,关于麻醉品和毒品造成损害的认定问题及证明的可能性也日益重要。因此,有必要更深入地研究美国的“药物评估与分类计划”,并考虑在德国应用该计划。美国的这个计划基于对药物识别专家学员的标准化培训以及经过充分测试的检查方法。其结果令人信服。检查人员编写的专家报告与化学毒理学结果在80%至97%的案例中相互关联。只要不存在关于剂量/浓度效应关系的确切结论,行为、外貌和医学检查的分类就起着重要作用。在很大程度上,该计划也考虑到了德国现有的可能性。本文作者认为,如果在德国引入这样一个计划之前进行广泛、耗时的实地研究以获取更多知识,那将是错误的。另一方面,尽管存在困难,但仍应努力找出剂量/浓度效应。